-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HbVZRiW3gNQA9awJzkCsFvtnEvOeWkf4hmlTFwhWszdz85MMnXDEaXv2mBLv3g61 Gpojt3qZB943FDi+Deed4Q== 0001358010-06-000008.txt : 20060421 0001358010-06-000008.hdr.sgml : 20060421 20060421175646 ACCESSION NUMBER: 0001358010-06-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060420 FILED AS OF DATE: 20060421 DATE AS OF CHANGE: 20060421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE TECHNOLOGY INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 981 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: 7143611200 MAIL ADDRESS: STREET 1: 981 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 FORMER COMPANY: FORMER CONFORMED NAME: PAMPLONA CAPITAL CORP DATE OF NAME CHANGE: 19911104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DURRIE DANIEL S CENTRAL INDEX KEY: 0001358010 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19627 FILM NUMBER: 06773639 BUSINESS ADDRESS: BUSINESS PHONE: 949 361-1200 MAIL ADDRESS: STREET 1: C/O BIOLASE TECHNOLOGY INC STREET 2: 981 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-04-20 0 0000811240 BIOLASE TECHNOLOGY INC BLTI 0001358010 DURRIE DANIEL S C/O BIOLASE TECHNOLOGY INC 981 CALLE AMANECER SAN CLEMENTE CA 92673 1 0 0 0 Stock Option (right to buy) 10.4 2006-04-20 4 A 0 10000 0 A 2016-04-20 Common Stock 10000 10000 D Each automatic option is immediately exercisable for all of the option shares. However, any shares purchased under such option are subject to repurchase by the Issuer, at the lower of the exercise price paid per share or the fair market value per share (determined at the time of repurchase), should the Reporting Person cease Board service prior to vesting of those shares. The shares vest, and the Company's right of repurchase lapses, in four successive quarterly installments upon the Reporting Person's completion of each quarter of service as a non-employee director measured from the grant date. The shares subject to the option grant will immediately vest in full if certain changes in control or ownership occur or if the Reporting Person dies or becomes disabled while serving as a director. /s/ Richard L. Harrison, Attorney-in-Fact 2006-04-21 -----END PRIVACY-ENHANCED MESSAGE-----